Marksans Pharma block deals, bulk deals, insider trading and stake changes
NSE: MARKSANSBSE: 524404Pharmaceuticals & BiotechnologySmall Cap
Formerly Tasc Pharmaceuticals
Last close ₹286.90down ₹7.55 (2.56%)BSE ₹286.75
Share price at the NSE close on 23 Oct 2026. Previous close ₹294.45.
52-week range of traded prices to 23 Oct 2026
₹155.00Low, 30 Mar 2026₹350.95High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹13,001 Cr592nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 25.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 4.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 12 Aug 2026
- 17.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 14,14,61953.0% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Marksans Pharma promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Directors and key managers: no market trade · 1 off-market move
- Others: no market trade · 3 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Marksans Pharma insider trading
All 25 disclosures on record.Insider trading, all companies
Sep 2026
- Marise Ann Saldanha20,000sharesReceived · Directors Immediate Relative · 11 Sep 2026 · disclosed 15 Sep · Gift · held none before, holds 20,000 after
- Schenelle Megan Saldanha1,45,000sharesReceived · Directors Immediate Relative · 11 Sep 2026 · disclosed 15 Sep · Gift · held none before, holds 1,45,000 after, stake 0.03% after
- Merrill Jean Saldanha63,273sharesReceived · Directors Immediate Relative · 11 Sep 2026 · disclosed 15 Sep · Gift · held none before, holds 63,273 after, stake 0.01% after
- Sandra Saldanha2,28,273sharesGave · Director · 11 Sep 2026 · disclosed 15 Sep · Gift · stake 0.07% before, 0.02% after
Jun 2024
- Sandra Saldanha₹0.90 Cr63,276 sharesBought · 5 Jun 2024 · disclosed 6 Jun · stake 0.06% before, 0.07% after
- Sandra Saldanha₹0.69 Cr47,000 sharesBought · 3 Jun 2024 · disclosed 4 Jun · stake 0.05% before, 0.06% after
Aug 2023
- Arvind Raghuvir Singh₹0.03 Cr3,000 sharesBought · Designated Person · 16 Aug 2023 · disclosed 23 Aug
- Arvind Raghuvir Singh₹0.06 Cr5,000 sharesSold or invoked · Designated Person · 16 Aug 2023 · disclosed 23 Aug
- Arvind Singh₹0.03 Cr2,000 sharesSold · 14 Aug 2023 · disclosed 18 Aug · held 5,000 before, holds 3,000 after
- Arvind Singh₹0.03 Cr3,000 sharesBought · 14 Aug 2023 · disclosed 18 Aug · holds 3,000 after
- Arvind Singh₹0.08 Cr6,500 sharesSold · 14 Aug 2023 · disclosed 18 Aug · held 11,500 before, holds 5,000 after
- Arvind Singh₹0.03 Cr3,000 sharesSold · 14 Aug 2023 · disclosed 18 Aug · held 3,000 before
- Arvind Raghuvir Singh₹0.02 Cr1,500 sharesBought · Designated Person · 14 Aug 2023 · disclosed 19 Aug
- Arvind Raghuvir Singh₹0.09 Cr8,000 sharesSold or invoked · Designated Person · 14 Aug 2023 · disclosed 19 Aug
Mar 2023
- Sandra Saldanha₹0.97 Cr1,45,000 sharesBought · 14 Mar 2023 · disclosed 15 Mar · stake 0.02% before, 0.05% after
Feb 2023
- Sandra Saldanha₹0.51 Cr75,000 sharesBought · Promoters · 27 Feb 2023 · disclosed 28 Feb · held 180 before, holds 75,180 after, stake 0.02% after
- Mark Saldanha₹7.40 Cr10,00,000 sharesReceived · 17 Feb 2023 · disclosed 20 Feb · Conversion of security · stake 43.58% before, 43.80% after
Jun 2021
- Mark Saldanha₹1,867 Cr19,74,91,553 sharesSold or invoked · Promoter And Designated Person · 15 Jun 2021 · disclosed 24 Jun
- Mark Saldanha₹1,867 Cr19,74,91,553 sharesBought · Promoter And Designated Person · 15 Jun 2021 · disclosed 24 Jun
Earlier, Jul 2015 to Sep 2016Hide earlier
Sep 2016
- Harsh Trehon₹0.35 Cr69,900 sharesGave · Employee · 21 Sep 2016 · Market · held 69,900 before
- HARSH TREHON₹0.35 Cr69,900 sharesSold · Employees/Designated Employees · 20 Sep 2016 · disclosed 21 Sep · held 69,900 before
Aug 2015
- Mr. Sebastian Pereira₹0.06 Cr5,100 sharesSold · Employees/Designated Employees · 7 Aug 2015 · disclosed 2 Mar 2020 · held 40,958 before, holds 35,858 after
Jul 2015
- Mr. Sebastian Pereira₹10,463100 sharesBought · Employees/Designated Employees · 31 Jul 2015 · disclosed 2 Mar 2020 · held 40,858 before, holds 40,958 after
- Mr. Sebastian Pereira₹0.03 Cr2,800 sharesSold · Employees/Designated Employees · 24 Jul 2015 · disclosed 2 Mar 2020 · held 43,658 before, holds 40,858 after
- Mr. Sebastian Pereira₹0.04 Cr5,000 sharesSold · Employees/Designated Employees · 3 Jul 2015 · disclosed 2 Mar 2020 · held 48,658 before, holds 43,658 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Marksans Pharma stake sales and purchases
All 5 disclosures on record.
Jun 2025
- SoldOrbiMed Asia IV Mauritius FVCI Limited2.27% of the company1,02,73,443 sharesholds 8.62% after11 Jun 2025 · filed under the 2% rule
Mar 2023
- AcquiredMrs. Sandra Saldanha alongwith PAC · promoterholds 0.05% after14 Mar 2023 · filed under the 2% rule
Feb 2023
- AcquiredMrs. Sandra Saldanha alongwith PAC · promoter0.02% of the company75,000 sharesholds 0.02% after27 Feb 2023 · filed under the 2% rule
Jan 2023
- AcquiredMark Saldanha · promoter0.22% of the company10,00,000 sharesholds 43.80% after20 Jan 2023 · filed under the 2% rule
- AcquiredOrbiMed Asia IV Mauritius FVCI Limited10.88% of the company4,93,24,324 sharesholds 12.05% after20 Jan 2023 · filed under the 5% rule
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Marksans Pharma block deals and bulk deals
Last 12 months, since 23 Oct 2025: 2 bulk deals, ₹136 Cr bought and ₹136 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 12 Aug 20261 firm · ₹136 Cr bought · ₹136 Cr soldNet sold ₹0.07 Cr
- Both waysMICROCURVES TRADING PRIVATE LIMITEDBought 43,49,697 at ₹313.24Sold 43,49,697 at ₹313.400.96% of the companyNet nil₹136 Cr bought
Monday 28 Jul 20251 firm · ₹168 Cr bought · ₹0 soldNet bought ₹168 Cr
- BoughtUNIFI CAPITAL PRIVATE LIMITEDBought 72,41,309 at ₹231.501.60% of the company₹168 Cr
Wednesday 11 Jun 202513 firms · ₹413 Cr bought · ₹514 Cr soldNet sold ₹101 Cr
- SoldORBIMED ASIA IV MAURITIUS FVCI LIMITEDBlock dealSold 1,02,73,443 at ₹249.952.27% of the company₹257 Cr
- SoldORBIMED ASIA IV MAURITIUS FVCI LIMITEDSold 1,02,73,443 at ₹249.952.27% of the company₹257 Cr
- BoughtUNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLIBlock dealBought 32,47,600 at ₹249.950.72% of the company₹81 Cr
- BoughtUNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLIBought 32,47,600 at ₹249.950.72% of the company₹81 Cr
- BoughtUNIFI BLEND FUND 2Block dealBought 30,00,000 at ₹249.950.66% of the company₹75 Cr
- BoughtUNIFI BLEND FUND 2Bought 30,00,000 at ₹249.950.66% of the company₹75 Cr
- BoughtSOCIETE GENERALEBlock dealBought 9,20,184 at ₹249.950.20% of the company₹23 Cr
- BoughtBANDHAN MUTUAL FUNDBlock dealBought 6,00,000 at ₹249.950.13% of the company₹15 Cr
- BoughtUNIFI CAPITAL PRIVATE LIMITEDBlock dealBought 5,94,000 at ₹249.950.13% of the company₹15 Cr
- BoughtUNIFI BCAD FUNDBlock dealBought 5,60,000 at ₹249.950.12% of the company₹14 Cr
- BoughtSUBHKAM VENTURES I PRIVATE LIMITEDBlock dealBought 5,37,485 at ₹249.950.12% of the company₹13 Cr
- BoughtUTI MUTUAL FUNDBlock dealBought 4,14,093 at ₹249.950.09% of the company₹10 Cr
- BoughtCITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITEDBlock dealBought 4,00,081 at ₹249.950.09% of the company₹10 Cr
Friday 20 Sep 20244 firms · ₹233 Cr bought · ₹183 Cr soldNet bought ₹50 Cr
- SoldUBS PRINCIPAL CAPITAL ASIA LIMITEDSold 34,01,630 at ₹317.220.75% of the company₹108 Cr
- BoughtVANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDBought 26,97,280 at ₹316.850.60% of the company₹85 Cr
- BoughtVANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VANGUARD INTERNATIONAL EQUITY INDEX FUNDSBought 23,01,640 at ₹316.850.51% of the company₹73 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 24,51,180 at ₹305.27Sold 24,51,180 at ₹305.270.54% of the companyNet nil₹75 Cr bought
Monday 15 Apr 20241 firm · ₹104 Cr bought · ₹0 soldNet bought ₹104 Cr
- BoughtMASSACHUSETTS INSTITUTE OF TECHNOLOGYBought 66,00,000 at ₹158.001.46% of the company₹104 Cr
Tuesday 15 Jun 20212 firms · ₹55 Cr bought · ₹54 Cr soldNet bought ₹0.98 Cr
- Both waysCRONY VYAPAR PVT LTDBought 29,00,172 at ₹93.75Sold 28,00,172 at ₹93.690.71% of the companyNet +1,00,000 shares₹27 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 30,04,279 at ₹93.18Sold 30,04,279 at ₹93.090.73% of the companyNet nil₹28 Cr bought
Monday 14 Jun 20214 firms · ₹124 Cr bought · ₹124 Cr soldNet sold ₹0.34 Cr
- Both waysPARTH INFIN BROKERS PVT LTDBought 30,11,733 at ₹94.60Sold 30,26,733 at ₹94.880.74% of the companyNet −15,000 shares₹28 Cr bought
- Both waysXTX MARKETS LLPBought 28,14,707 at ₹92.19Sold 28,14,707 at ₹92.420.69% of the companyNet nil₹26 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 47,72,250 at ₹92.29Sold 47,72,250 at ₹92.371.17% of the companyNet nil₹44 Cr bought
- Both waysVAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITEDBought 27,55,545 at ₹90.87Sold 27,55,545 at ₹90.910.67% of the companyNet nil₹25 Cr bought
Friday 23 Apr 20211 firm · ₹19 Cr bought · ₹19 Cr soldNet sold ₹0.05 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 25,72,646 at ₹73.13Sold 25,72,646 at ₹73.330.63% of the companyNet nil₹19 Cr bought
Friday 21 Sep 20181 firm · ₹0 bought · ₹7.79 Cr soldNet sold ₹7.79 Cr
- SoldTHE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDESold 23,43,202 at ₹33.230.57% of the company₹7.79 Cr
Monday 6 Aug 20181 firm · ₹7.42 Cr bought · ₹7.52 Cr soldNet sold ₹0.10 Cr
- Both waysPARTH INFIN BROKERS PVT LTDBought 22,45,387 at ₹33.05Sold 22,70,387 at ₹33.110.55% of the companyNet −25,000 shares₹7.42 Cr bought
Monday 10 Apr 20171 firm · ₹16 Cr bought · ₹16 Cr soldNet sold ₹88,726
- Both waysSHAASTRA SECURITIES TRADING PRIVATE LIMITEDBought 29,57,519 at ₹55.29Sold 29,57,519 at ₹55.320.72% of the companyNet nil₹16 Cr bought
Tuesday 20 Sep 20161 firm · ₹19 Cr bought · ₹19 Cr soldNet bought ₹0.02 Cr
- Both waysPARTH INFIN BROKERS PVT LTDBought 38,30,711 at ₹49.31Sold 38,26,611 at ₹49.300.94% of the companyNet +4,100 shares₹19 Cr bought
Friday 18 Mar 20161 firm · ₹12 Cr bought · ₹0 soldNet bought ₹12 Cr
- BoughtVANGUARD INTERNATIONAL EXPLORER FUNDBought 23,66,133 at ₹50.090.58% of the company₹12 Cr
Friday 19 Dec 20141 firm · ₹13 Cr bought · ₹0 soldNet bought ₹13 Cr
- BoughtVAN ECK VIP EMERGING MARKETS FUNDBought 21,26,130 at ₹61.390.55% of the company₹13 Cr
Wednesday 4 Jun 20141 firm · ₹0 bought · ₹17 Cr soldNet sold ₹17 Cr
- SoldBARNACLE LLCSold 84,00,241 at ₹20.362.18% of the company₹17 Cr
Friday 12 Nov 20101 firm · ₹1.70 Cr bought · ₹1.34 Cr soldNet bought ₹0.37 Cr
- Both waysJMP SECURITIES PVT LTDBought 32,74,591 at ₹5.20Sold 25,69,591 at ₹5.20Net +7,05,000 shares₹1.70 Cr bought
Monday 31 Aug 20091 firm · ₹3.67 Cr bought · ₹3.19 Cr soldNet bought ₹0.48 Cr
- Both waysJMP SECURITIES PVT LTDBought 55,69,637 at ₹6.59Sold 48,45,649 at ₹6.58Net +7,23,988 shares₹3.67 Cr bought
Tuesday 16 Jun 20091 firm · ₹1.01 Cr bought · ₹1.04 Cr soldNet sold ₹0.04 Cr
- Both waysANGEL INFIN PRIVATE LIMITEDBought 18,40,055 at ₹5.47Sold 18,40,065 at ₹5.67Net −10 shares₹1.01 Cr bought
Monday 2 Mar 20091 firm · ₹0 bought · ₹1.11 Cr soldNet sold ₹1.11 Cr
- SoldSANGAM FISCALS & HOLDINGS PVT LTDSold 20,50,000 at ₹5.40₹1.11 Cr
Tuesday 18 Nov 20082 firms · ₹1.20 Cr bought · ₹1.20 Cr soldNet nil
- BoughtANJALI CHAWLABlock dealBought 19,95,747 at ₹6.03₹1.20 Cr
- SoldKABUL CHAWLABlock dealSold 19,95,747 at ₹6.03₹1.20 Cr
Tuesday 2 Sep 20081 firm · ₹0 bought · ₹6.07 Cr soldNet sold ₹6.07 Cr
- SoldXITIJ INVESTMENTSSold 33,25,000 at ₹18.25₹6.07 Cr
Friday 23 May 20081 firm · ₹3.81 Cr bought · ₹0 soldNet bought ₹3.81 Cr
- BoughtSHRADHA TRADELINKS PVT LTDBought 18,00,000 at ₹21.15₹3.81 Cr
SplitEach share became 10 on 11 Mar 2008. The lines below are on the share count before it.
Friday 22 Feb 20081 firm · ₹4.39 Cr bought · ₹0 soldNet bought ₹4.39 Cr
- BoughtDHWANI M DOSHIBought 1,86,471 at ₹235.35₹4.39 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. The latest 58 deals, on record from 4 Jan 2004.